 Michael Kahn
Concepts (250)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electronic Health Records | 21 | 2021 | 800 | 2.910 |
Why?
| | Medical Informatics | 6 | 2017 | 90 | 1.760 |
Why?
| | Data Accuracy | 6 | 2022 | 48 | 1.620 |
Why?
| | Biomedical Research | 9 | 2018 | 585 | 1.490 |
Why?
| | Pediatrics | 5 | 2019 | 980 | 1.300 |
Why?
| | Medical Record Linkage | 8 | 2020 | 53 | 1.230 |
Why?
| | Crowding | 3 | 2011 | 37 | 1.120 |
Why?
| | Health Services Research | 3 | 2019 | 371 | 0.970 |
Why?
| | Computer Communication Networks | 2 | 2014 | 32 | 0.920 |
Why?
| | Comparative Effectiveness Research | 5 | 2017 | 130 | 0.910 |
Why?
| | Quality of Health Care | 4 | 2013 | 573 | 0.840 |
Why?
| | Rare Diseases | 1 | 2023 | 89 | 0.810 |
Why?
| | Data Warehousing | 1 | 2022 | 5 | 0.800 |
Why?
| | Cloud Computing | 1 | 2022 | 6 | 0.800 |
Why?
| | Patient-Centered Care | 3 | 2014 | 473 | 0.710 |
Why?
| | Machine Learning | 2 | 2023 | 316 | 0.710 |
Why?
| | Information Storage and Retrieval | 5 | 2020 | 106 | 0.690 |
Why?
| | Quality Assurance, Health Care | 3 | 2012 | 311 | 0.640 |
Why?
| | Urology | 1 | 2018 | 46 | 0.580 |
Why?
| | Clinical Trials as Topic | 3 | 2013 | 932 | 0.570 |
Why?
| | Child Health | 1 | 2019 | 127 | 0.570 |
Why?
| | Databases, Factual | 6 | 2019 | 1125 | 0.540 |
Why?
| | Medical Records Systems, Computerized | 4 | 2012 | 88 | 0.510 |
Why?
| | Data Mining | 2 | 2017 | 100 | 0.510 |
Why?
| | Child Welfare | 2 | 2014 | 192 | 0.490 |
Why?
| | Terminology as Topic | 2 | 2014 | 187 | 0.470 |
Why?
| | Quality Improvement | 1 | 2021 | 950 | 0.450 |
Why?
| | Forms and Records Control | 1 | 2013 | 22 | 0.450 |
Why?
| | Community Networks | 1 | 2014 | 54 | 0.440 |
Why?
| | Quality Indicators, Health Care | 3 | 2013 | 287 | 0.420 |
Why?
| | Population Surveillance | 3 | 2020 | 392 | 0.410 |
Why?
| | Humans | 54 | 2024 | 114689 | 0.380 |
Why?
| | Wearable Electronic Devices | 2 | 2021 | 34 | 0.370 |
Why?
| | Nursing Assessment | 1 | 2011 | 49 | 0.370 |
Why?
| | Analgesia | 1 | 2011 | 82 | 0.360 |
Why?
| | Emergency Service, Hospital | 2 | 2011 | 1815 | 0.360 |
Why?
| | Child | 17 | 2020 | 18415 | 0.350 |
Why?
| | Models, Statistical | 2 | 2019 | 599 | 0.340 |
Why?
| | Mass Screening | 2 | 2020 | 1004 | 0.340 |
Why?
| | United States | 18 | 2022 | 12183 | 0.340 |
Why?
| | Information Dissemination | 3 | 2019 | 186 | 0.330 |
Why?
| | Adverse Drug Reaction Reporting Systems | 1 | 2010 | 68 | 0.330 |
Why?
| | Decision Support Systems, Clinical | 2 | 2023 | 176 | 0.330 |
Why?
| | Heart Defects, Congenital | 3 | 2020 | 671 | 0.330 |
Why?
| | Pain | 2 | 2011 | 705 | 0.320 |
Why?
| | Accidental Falls | 1 | 2011 | 151 | 0.320 |
Why?
| | Diabetes Mellitus, Type 2 | 5 | 2020 | 2096 | 0.290 |
Why?
| | Organizational Policy | 1 | 2007 | 68 | 0.280 |
Why?
| | beta Catenin | 2 | 2023 | 219 | 0.280 |
Why?
| | Pregnenes | 1 | 2006 | 1 | 0.270 |
Why?
| | Fluorine | 1 | 2006 | 15 | 0.270 |
Why?
| | Adolescent | 16 | 2022 | 17848 | 0.250 |
Why?
| | Child, Preschool | 9 | 2020 | 9116 | 0.240 |
Why?
| | Diabetes Mellitus, Type 1 | 5 | 2020 | 3252 | 0.240 |
Why?
| | Receptors, Glucocorticoid | 1 | 2006 | 130 | 0.240 |
Why?
| | Emergency Medical Services | 1 | 2011 | 590 | 0.230 |
Why?
| | Pyrazoles | 1 | 2006 | 362 | 0.210 |
Why?
| | Infant | 7 | 2020 | 7963 | 0.210 |
Why?
| | Pyridines | 1 | 2006 | 425 | 0.210 |
Why?
| | Adrenal Cortex Hormones | 1 | 2006 | 497 | 0.210 |
Why?
| | Precision Medicine | 2 | 2024 | 337 | 0.210 |
Why?
| | Data Collection | 3 | 2014 | 620 | 0.200 |
Why?
| | Time Factors | 4 | 2014 | 6116 | 0.190 |
Why?
| | Asthma | 2 | 2011 | 2029 | 0.190 |
Why?
| | Life Cycle Stages | 1 | 2021 | 32 | 0.190 |
Why?
| | Education, Distance | 1 | 2021 | 38 | 0.180 |
Why?
| | Young Adult | 8 | 2020 | 10470 | 0.180 |
Why?
| | India | 4 | 2020 | 134 | 0.170 |
Why?
| | Information Services | 1 | 2019 | 44 | 0.160 |
Why?
| | Information Management | 2 | 2012 | 15 | 0.160 |
Why?
| | Sentinel Surveillance | 2 | 2018 | 38 | 0.160 |
Why?
| | Acute Disease | 2 | 2011 | 911 | 0.160 |
Why?
| | Penicillin Resistance | 1 | 1998 | 8 | 0.160 |
Why?
| | Reproducibility of Results | 4 | 2021 | 2765 | 0.160 |
Why?
| | Infant, Newborn | 5 | 2020 | 5047 | 0.160 |
Why?
| | Male | 15 | 2020 | 55599 | 0.150 |
Why?
| | Research Design | 4 | 2021 | 928 | 0.150 |
Why?
| | Diabetic Ketoacidosis | 1 | 2020 | 159 | 0.150 |
Why?
| | Pneumococcal Infections | 1 | 1998 | 91 | 0.150 |
Why?
| | Colorado | 7 | 2024 | 4099 | 0.140 |
Why?
| | Female | 15 | 2020 | 59511 | 0.140 |
Why?
| | Pragmatic Clinical Trials as Topic | 1 | 2017 | 47 | 0.140 |
Why?
| | Datasets as Topic | 1 | 2017 | 100 | 0.140 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2017 | 106 | 0.140 |
Why?
| | Cross-Sectional Studies | 3 | 2011 | 4410 | 0.140 |
Why?
| | Acute Kidney Injury | 1 | 2023 | 638 | 0.140 |
Why?
| | Fractures, Bone | 2 | 2011 | 367 | 0.130 |
Why?
| | Cross Infection | 1 | 1998 | 197 | 0.130 |
Why?
| | Adult | 9 | 2022 | 30550 | 0.130 |
Why?
| | Logistic Models | 2 | 2011 | 1841 | 0.130 |
Why?
| | Hospitals, University | 2 | 2011 | 172 | 0.130 |
Why?
| | Vocabulary, Controlled | 2 | 2014 | 41 | 0.130 |
Why?
| | Phenotype | 1 | 2023 | 2796 | 0.120 |
Why?
| | Product Surveillance, Postmarketing | 1 | 2015 | 63 | 0.120 |
Why?
| | Algorithms | 3 | 2020 | 1469 | 0.120 |
Why?
| | Program Development | 2 | 2019 | 341 | 0.110 |
Why?
| | Hospitals, Pediatric | 1 | 2017 | 480 | 0.110 |
Why?
| | Hydronephrosis | 1 | 2014 | 28 | 0.110 |
Why?
| | Database Management Systems | 2 | 2012 | 47 | 0.110 |
Why?
| | Chronic Disease | 1 | 2019 | 1578 | 0.110 |
Why?
| | Organizational Innovation | 1 | 2014 | 132 | 0.110 |
Why?
| | Odds Ratio | 2 | 2011 | 953 | 0.110 |
Why?
| | Cardiovascular Surgical Procedures | 1 | 2013 | 29 | 0.110 |
Why?
| | Patient Handoff | 1 | 2013 | 26 | 0.110 |
Why?
| | Interinstitutional Relations | 1 | 2013 | 54 | 0.110 |
Why?
| | Patient Identification Systems | 1 | 2013 | 16 | 0.110 |
Why?
| | Models, Theoretical | 2 | 2017 | 515 | 0.100 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2015 | 238 | 0.100 |
Why?
| | Multicenter Studies as Topic | 1 | 2013 | 249 | 0.100 |
Why?
| | Diabetes Mellitus | 1 | 2020 | 900 | 0.100 |
Why?
| | Registries | 4 | 2020 | 1768 | 0.100 |
Why?
| | Postoperative Period | 1 | 2013 | 289 | 0.100 |
Why?
| | Risk Assessment | 2 | 2011 | 2968 | 0.100 |
Why?
| | Operating Rooms | 1 | 2013 | 86 | 0.100 |
Why?
| | Ethics Committees, Research | 1 | 2012 | 38 | 0.100 |
Why?
| | Documentation | 1 | 2013 | 167 | 0.100 |
Why?
| | Narcotics | 1 | 2011 | 44 | 0.090 |
Why?
| | Bed Occupancy | 1 | 2011 | 10 | 0.090 |
Why?
| | Research | 1 | 2014 | 394 | 0.090 |
Why?
| | Confidence Intervals | 1 | 2011 | 305 | 0.090 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2012 | 153 | 0.090 |
Why?
| | Heart Failure | 1 | 2023 | 1945 | 0.090 |
Why?
| | Intensive Care Units, Pediatric | 1 | 2012 | 148 | 0.090 |
Why?
| | Ambulatory Care | 1 | 2014 | 478 | 0.090 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2012 | 167 | 0.090 |
Why?
| | Joint Commission on Accreditation of Healthcare Organizations | 1 | 2010 | 7 | 0.090 |
Why?
| | Intubation, Intratracheal | 1 | 2012 | 216 | 0.090 |
Why?
| | Analgesics | 1 | 2011 | 158 | 0.090 |
Why?
| | Cooperative Behavior | 1 | 2012 | 381 | 0.080 |
Why?
| | Needs Assessment | 1 | 2011 | 314 | 0.080 |
Why?
| | Patient Safety | 1 | 2013 | 277 | 0.080 |
Why?
| | Child, Hospitalized | 1 | 2010 | 38 | 0.080 |
Why?
| | Injury Severity Score | 1 | 2011 | 499 | 0.080 |
Why?
| | Pain Measurement | 1 | 2011 | 444 | 0.080 |
Why?
| | Overweight | 1 | 2013 | 472 | 0.080 |
Why?
| | Radiography | 1 | 2011 | 812 | 0.080 |
Why?
| | Pilot Projects | 1 | 2013 | 1373 | 0.080 |
Why?
| | Workflow | 1 | 2010 | 133 | 0.080 |
Why?
| | Intensive Care Units | 1 | 2013 | 617 | 0.080 |
Why?
| | Pain Management | 1 | 2011 | 288 | 0.080 |
Why?
| | Retrospective Studies | 4 | 2011 | 12551 | 0.080 |
Why?
| | Pulmonary Fibrosis | 1 | 2012 | 323 | 0.080 |
Why?
| | Age of Onset | 2 | 2020 | 446 | 0.080 |
Why?
| | Patient Care Team | 1 | 2012 | 517 | 0.070 |
Why?
| | Anti-Asthmatic Agents | 1 | 2011 | 349 | 0.070 |
Why?
| | Inpatients | 1 | 2011 | 380 | 0.070 |
Why?
| | Internet | 1 | 2012 | 596 | 0.070 |
Why?
| | Multivariate Analysis | 1 | 2011 | 1430 | 0.070 |
Why?
| | Pediatric Obesity | 1 | 2013 | 489 | 0.070 |
Why?
| | Stereoisomerism | 1 | 2006 | 91 | 0.070 |
Why?
| | Epithelial Cells | 1 | 2012 | 951 | 0.070 |
Why?
| | Microwaves | 1 | 2006 | 31 | 0.060 |
Why?
| | Ambulatory Care Information Systems | 1 | 2005 | 5 | 0.060 |
Why?
| | Structure-Activity Relationship | 1 | 2006 | 502 | 0.060 |
Why?
| | Molecular Structure | 1 | 2006 | 434 | 0.060 |
Why?
| | Animals | 4 | 2023 | 31706 | 0.060 |
Why?
| | Patient Readmission | 1 | 2010 | 610 | 0.060 |
Why?
| | Positron-Emission Tomography | 1 | 2006 | 259 | 0.060 |
Why?
| | Healthcare Disparities | 1 | 2010 | 480 | 0.060 |
Why?
| | Aqueous Humor | 2 | 1983 | 31 | 0.060 |
Why?
| | Analgesics, Opioid | 1 | 2011 | 771 | 0.060 |
Why?
| | Computational Biology | 2 | 2019 | 530 | 0.060 |
Why?
| | Evidence-Based Medicine | 1 | 2008 | 668 | 0.060 |
Why?
| | Exercise | 1 | 2014 | 1644 | 0.060 |
Why?
| | Health Services Accessibility | 1 | 2010 | 763 | 0.060 |
Why?
| | Glycogen Storage Disease Type I | 1 | 2023 | 5 | 0.060 |
Why?
| | Prevalence | 2 | 2019 | 2251 | 0.050 |
Why?
| | Biological Specimen Banks | 1 | 2024 | 94 | 0.050 |
Why?
| | Trabecular Meshwork | 1 | 1983 | 77 | 0.050 |
Why?
| | Kinetics | 1 | 2006 | 1551 | 0.050 |
Why?
| | Health Insurance Portability and Accountability Act | 1 | 2022 | 12 | 0.050 |
Why?
| | Glutathione | 1 | 1983 | 293 | 0.050 |
Why?
| | Glucocorticoids | 1 | 2006 | 532 | 0.050 |
Why?
| | Sensitivity and Specificity | 1 | 2006 | 1693 | 0.050 |
Why?
| | Appointments and Schedules | 1 | 2002 | 72 | 0.050 |
Why?
| | Fitness Trackers | 1 | 2021 | 8 | 0.050 |
Why?
| | Collagen | 1 | 2023 | 415 | 0.050 |
Why?
| | Fibrosis | 1 | 2023 | 453 | 0.050 |
Why?
| | Clinical Protocols | 1 | 2002 | 233 | 0.040 |
Why?
| | Artificial Intelligence | 1 | 2002 | 144 | 0.040 |
Why?
| | Insurance Claim Reporting | 1 | 2020 | 22 | 0.040 |
Why?
| | Middle Aged | 4 | 2020 | 26737 | 0.040 |
Why?
| | Cohort Studies | 2 | 2022 | 4895 | 0.040 |
Why?
| | Probability | 1 | 2020 | 289 | 0.040 |
Why?
| | Genomics | 1 | 2024 | 635 | 0.040 |
Why?
| | Demography | 1 | 2020 | 260 | 0.040 |
Why?
| | Surveys and Questionnaires | 2 | 2021 | 4623 | 0.040 |
Why?
| | Bias | 1 | 2020 | 179 | 0.040 |
Why?
| | Signal Transduction | 1 | 2012 | 4513 | 0.040 |
Why?
| | Missouri | 1 | 1998 | 61 | 0.040 |
Why?
| | Consumer Product Safety | 1 | 2018 | 30 | 0.040 |
Why?
| | Computer Systems | 1 | 2018 | 45 | 0.040 |
Why?
| | Linear Models | 1 | 2019 | 768 | 0.040 |
Why?
| | Community-Acquired Infections | 1 | 1998 | 141 | 0.030 |
Why?
| | Students | 1 | 2021 | 502 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2020 | 1796 | 0.030 |
Why?
| | Health Planning Guidelines | 1 | 2014 | 25 | 0.030 |
Why?
| | Calibration | 1 | 2014 | 125 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 1317 | 0.030 |
Why?
| | Semantics | 1 | 2014 | 89 | 0.030 |
Why?
| | Incidence | 1 | 2020 | 2313 | 0.030 |
Why?
| | Follow-Up Studies | 2 | 2014 | 4411 | 0.030 |
Why?
| | Names | 1 | 2013 | 12 | 0.030 |
Why?
| | Systems Integration | 1 | 2013 | 37 | 0.030 |
Why?
| | Research Personnel | 1 | 2014 | 149 | 0.030 |
Why?
| | Airway Extubation | 1 | 2013 | 43 | 0.030 |
Why?
| | Quality Control | 1 | 2013 | 144 | 0.030 |
Why?
| | CREB-Binding Protein | 1 | 2012 | 27 | 0.020 |
Why?
| | Medical Errors | 1 | 2013 | 85 | 0.020 |
Why?
| | Smad3 Protein | 1 | 2012 | 41 | 0.020 |
Why?
| | Prospective Studies | 2 | 2014 | 6220 | 0.020 |
Why?
| | Oxygen Consumption | 1 | 2014 | 588 | 0.020 |
Why?
| | Pyrimidinones | 1 | 2012 | 88 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2014 | 740 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2017 | 2387 | 0.020 |
Why?
| | Academic Medical Centers | 1 | 2013 | 411 | 0.020 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2012 | 172 | 0.020 |
Why?
| | Actins | 1 | 2012 | 381 | 0.020 |
Why?
| | Respiration, Artificial | 1 | 2013 | 529 | 0.020 |
Why?
| | Mice | 1 | 2023 | 14869 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2020 | 9088 | 0.020 |
Why?
| | Cell Line | 1 | 2012 | 2637 | 0.020 |
Why?
| | Body Mass Index | 1 | 2013 | 1959 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2013 | 1395 | 0.020 |
Why?
| | Hospitals | 1 | 2010 | 581 | 0.020 |
Why?
| | Information Centers | 1 | 2005 | 4 | 0.020 |
Why?
| | Databases as Topic | 1 | 2005 | 63 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2012 | 2187 | 0.010 |
Why?
| | Practice Patterns, Physicians' | 1 | 2013 | 1177 | 0.010 |
Why?
| | Biomarkers | 1 | 2014 | 3408 | 0.010 |
Why?
| | Diamide | 1 | 1983 | 4 | 0.010 |
Why?
| | Iodoacetates | 1 | 1983 | 3 | 0.010 |
Why?
| | Iodoacetamide | 1 | 1983 | 5 | 0.010 |
Why?
| | Ethylmaleimide | 1 | 1983 | 18 | 0.010 |
Why?
| | Carmustine | 1 | 1983 | 47 | 0.010 |
Why?
| | Sulfhydryl Reagents | 1 | 1983 | 11 | 0.010 |
Why?
| | Anterior Chamber | 1 | 1983 | 19 | 0.010 |
Why?
| | Free Radicals | 1 | 1983 | 99 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2012 | 2320 | 0.010 |
Why?
| | Lens, Crystalline | 1 | 1983 | 90 | 0.010 |
Why?
| | Rabbits | 1 | 1983 | 733 | 0.010 |
Why?
| | Hydrogen Peroxide | 1 | 1983 | 288 | 0.010 |
Why?
| | Time | 1 | 2002 | 70 | 0.010 |
Why?
| | Aged | 1 | 2019 | 19074 | 0.010 |
Why?
| | Cattle | 1 | 1983 | 920 | 0.010 |
Why?
| | Oxidation-Reduction | 1 | 1983 | 923 | 0.010 |
Why?
| | Amino Acids | 1 | 1983 | 448 | 0.010 |
Why?
| | Risk Factors | 1 | 2012 | 8632 | 0.010 |
Why?
| | Glucose | 1 | 1983 | 897 | 0.010 |
Why?
| | Decision Support Techniques | 1 | 2002 | 355 | 0.010 |
Why?
|
|
Kahn's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|